Barzolvolimab Chemical Properties

form 

Liquid

color 

Colorless to light yellow

Barzolvolimab Usage And Synthesis

Uses

Barzolvolimab (CDX 0159) is a humanized anti-KIT IgG1 monoclonal antibody. Barzolvolimab specificity and potently inhibits KIT activation by SCF. Barzolvolimab can reduce skin mast cells and disease activity in chronic inducible urticaria[1].

References

[1] Terhorst-Molawi D, et, al. Anti-KIT antibody, barzolvolimab, reduces skin mast cells and disease activity in chronic inducible urticaria. Allergy. 2022 Nov 16. DOI:10.1111/all.15585

Barzolvolimab(2438203-51-9)Related Product Information

• Ianalumab
• Relfovetmab
• Crenezumab
• Bezlotoxumab
• Begelomab
• Faricimab
• Tavolimab
• Merpentan
• Cilgavimab
• Docaravimab